IMC Chicago’s iShares Biotechnology ETF IBB Stock Holding History

IMC Chicago’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-29,400	Closed	-$4.75M	–	1233
2021 Q3	$4.75M	Buy	+29,400	New	+$4.95M	0.01%	630

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

IMC Chicago's IBB Position: Q4 2025 in Review

IMC Chicago sold out of iShares Biotechnology ETF (IBB) in Q4 2025, closing a stake of 10,712 shares — an estimated $1.55M sold.

IMC Chicago first reported a position in IBB in Q1 2020 and held it in 4 quarters. The position peaked at $2.35M in Q2 2021. 955 funds tracked by Wall St. Rank hold IBB as of Q4 2025.

IMC Chicago reported no remaining iShares Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
IMC Chicago sold 10,712 iShares Biotechnology ETF shares in Q4 2025, an estimated $1.55M.
IMC Chicago first reported a position in iShares Biotechnology ETF in Q1 2020 and held it in 4 quarters.
IMC Chicago's iShares Biotechnology ETF position peaked at $2.35M in Q2 2021.
955 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2025.

Based on IMC Chicago's 13F filing for Q4 2025, filed 29 Jan 2026.